Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid Malignancies.
Schulz F, Jäger P, Tischer J, Fraccaroli A, Bug G, Hausmann A, Baermann BN, Tressin P, Hoelscher A, Kasprzak A, Nachtkamp K, Schetelig J, Hilgendorf I, Germing U, Dietrich S, Kobbe G.
Schulz F, et al. Among authors: nachtkamp k.
Cancers (Basel). 2024 Jan 26;16(3):532. doi: 10.3390/cancers16030532.
Cancers (Basel). 2024.
PMID: 38339283
Free PMC article.